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Abstract
Background: The varied clinical presentations of Helicobacter pylori (H. pylori) infection are most likely due to
differences in the virulence of individual strains, which determines its ability to induce production of interleukin-8
(IL-8) in the gastric mucosa. The aim of this study was to examine association between cagA, vacA-s1 and vacA-s2
genotypes of H. pylori and severity of chronic gastritis and presence of peptic ulcer disease (PUD), and to correlate
these with IL-8 levels in the gastric mucosa.
Methods: Gastric mucosal biopsies were obtained from patients during esophagogastroduodenoscopy. The
severity of chronic gastritis was documented using the updated Sydney system. H. pylori cagA and vacA genotypes
were detected by PCR. The IL-8 levels in the gastric mucosa were measured by ELISA.
Results: H. pylori cagA and/or vacA genotypes were detected in 99 patients (mean age 38.4±12.9; 72 males), of
whom 52.5% were positive for cagA, 44.4% for vacA-s1 and 39.4% for vacA-s2; and 70.7% patients had PUD. The
severity of inflammation in gastric mucosa was increased with vacA-s1 (p=0.017) and decreased with vacA-s2
(p=0.025), while cagA had no association. The degree of neutrophil activity was not associated with either cagA or
vacA-s1, while vacA-s2 was significantly associated with decreased neutrophil activity (p=0.027). PUD was
significantly increased in patients with cagA (p=0.002) and vacA-s1 (p=0.031), and decreased in those with vacA-s2
(p=0.011). The level of IL-8 was significantly increased in patients with cagA (p=0.011) and vacA-s1 (p=0.024), and
lower with vacA-s2 (p=0.004). Higher levels of IL-8 were also found in patients with a more severe chronic
inflammation (p=0.001), neutrophil activity (p=0.007) and those with PUD (p=0.001).
Conclusions: Presence of vacA-s1 genotype of H. pylori is associated with more severe chronic inflammation and
higher levels of IL-8 in the gastric mucosa, as well as higher frequency of PUD. Patients with vacA-s2 have less
severe gastritis, lower levels of IL-8, and lower rates of PUD. The presence of cagA genotype is not associated with
the severity of gastritis or IL-8 induction in the gastric mucosa. The association of cagA with PUD may be a
reflection of its presence with vacA-s1 genotype.
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Background
Helicobacter pylori (H. pylori) colonizes the mucosa of
the human stomach and establishes a long-term infec-
tion [1]. It leads to the development of chronic gastritis,
peptic ulcer disease (PUD), mucosal-associated lymphoid
tissue (MALT) lymphoma and gastric carcinoma [2,3].
The extent and severity of these associations depend on
several elements, such as bacterial virulence factors, age
of the host, genetic susceptibility, immune response and
environmental factors [4-6].
The two key virulence markers of H. pylori are the cy-
totoxin associated A (cagA) and the vacuolating cyto-
toxin A (vacA) genes [6,7]. The cagA gene is not present
in every H. pylori strain, but is associated with more se-
vere clinical results such as more severe inflammation of
the gastric mucosa, as well as higher prevalence of PUD
and gastric carcinoma [8-10]. The vacA gene is present
in all H. pylori strains and is associated with PUD [11].
The vacA gene contains at least three variable regions,
the signal (s) region, intermediate (i) region and middle
(m) region. The s-region exists as s1 and s2 types
[12,13]. The vacA-s1 strains are associated with more se-
vere gastric inflammation and PUD independently of
cagA, while vacA-s2 strains are associated with lower
ulcer prevalence and less severe inflammation [14].
H. pylori infection results in recruitment of neutro-
phils, lymphocytes and macrophages into the gastric
mucosa through the induction of several cytokines such
as TNF-α, IL-6 and IL-8 [15-17]. IL-8 is an important
mediator in the immunopathogenesis of chronic gastritis
caused by H. pylori [16]. It has been demonstrated that
cagA and vacA-s1 positive strains of H. pylori induce
production of IL-8 in the gastric mucosa, both in vivo
and in vitro [16,18,19]. The vacA-s2 gene is not associ-
ated with IL-8 induction [18]. In addition, an association
between the mucosal levels of IL-8 and severity of gastri-
tis and presence of PUD has also been reported [19].
Most studies of association between genotypes of
H. pylori and chronic gastritis, peptic ulcer disease and
IL-8 levels have been conducted in the Western popula-
tions, and no previous study has examined these associa-
tions in the Middle East. Furthermore, the majority of
published studies have only examined either a single or
some of these associations.
The aim of this study was to determine the association
between the presence of cagA, vacA-s1 and vacA-s2 ge-
notypes in H. pylori and the severity of gastritis and
PUD, and to correlate these with the levels of IL-8 in a
group of patients from the Middle East. We have also
attempted to examine all these inter-related associations
in the same group of patients to validate the biologic
plausibility that the bacterial virulence factors lead to in-
duction of the cytokine IL-8, which in turn results in
more severe inflammation or development of PUD.
Results
Esophagogastroduodenoscopy and gastric biopsies were
performed in 120 adult patients. H. pylori were seen on
histopathology in 98 of these patients, all of whom were
positive for cagA and/or vacA. One patient had vacA on
PCR but was not positive for H. pylori on histopathology
was also included in the analysis. Therefore, further ana-
lysis was carried out in these 99 patients (72.7% males,
27.3% females; mean age 38.4 years) (Table 1). A history of
PUD was present in 27.3% of the patients, and the most
common indication for referral was dyspepsia (84.8%).
The most frequent abnormality seen on endoscopy was
PUD (70.7%) (Table 2). Endoscopic evidence of mucosal
inflammation of the stomach and duodenum was ob-
served in 57.6% and 29.3% of the patients, respectively.
Chronic inflammation was “None-Mild” in 22.2% of the
patients, and “Moderate-Marked” in 77.8%. Neutrophil ac-
tivity was “None-Mild” in 60.6%, and “Moderate-Marked”
in 39.4% of the patients.
Table 1 Socio-demographic and clinical characteristics of
99 patients with H. pylori infection in Kuwait
Characteristic
Age at diagnosis (years)
Mean ± SD 38.4 ± 12.9
Median 35.5
Range 18-75
Gender n (%)
Male 72 (72.7)
Female 27 (27.3)
Nationality
Kuwait 52 (52.5)
Bangladesh 15 (15.2)
Egypt 8 (8.1)
State-less Arabs 5 (5.1)
Syria 5 (5.1)
Othera 14 (14.1)
Past history of peptic ulcer disease 27 (27.3)
Past history of H. pylori infection 4 (4.0)
History of cigarette smoking 38 (38.4)
History of alcohol consumption 6 (6.1)
Indication for esophagogastroduodenoscopy
Dyspepsia 84 (84.8)
Upper gastrointestinal bleeding 6 (6.1)
Heartburn 5 (5.1)
Anemia 2 (2.0)
Persistent vomiting 2 (2.0)
aIndia (4), Iran (2), Pakistan (2), Saudi Arabia (2), Afghanistan (1), Jordan (1),
Somalia (1), Yemen (1).
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The presence of cagA, vacA-s1 and vacA-s2 genes was
found in 52.5%, 44.4% and 39.4% of the patients, while
10.1% were positive for both vacA-s1 vacA-s2. The cagA
gene was found in combination with vacA-s1 (cagA+ vacA-
s1) in 31.3% of the patients, with vacA-s2 (cagA+ vacA-s2)
in 8.1% and with both vacA-s1 and vacA-s2 (cagA+ vacA-
s1 + s2) in 7.1% of the patients. The IL-8 levels were
available in 77 patients with a median value of 1567.4 (IQR
1566.3) pg/mg protein.
Table 3 shows the association between the H. pylori
genotypes and severity of chronic inflammation, neutro-
phil activity and presence of PUD. Patients who were in-
fected with H. pylori containing both the cagA and
vacA-s1 genes were most likely to have “Moderate-
Marked” degree of chronic inflammation (OR = 6.7, 95%
CI: 1.4-31.4; p = 0.016). Patients with vacA-s1 gene
alone also had a significantly more “Moderate-Marked”
degree of chronic inflammation (OR = 3.9, 95% CI: 1.2-
12.0; p = 0.017), while those with vacA-s2 had signifi-
cantly less chronic inflammation (OR = 0.3, 95% CI: 0.1-
0.8; p = 0.025). The presence of cagA or vacA-s1 genes
either independently or together did not affect the se-
verity of neutrophil activity in the gastric biopsies. Pa-
tients with vacA-s2 gene had a significantly less
“Moderate-Marked” degree of neutrophil activity (OR =
0.3, 95% CI: 0.1-0.8; p = 0.027). The proportion of pa-
tients having PUD was highest in those with the cagA
gene (OR = 4.8, 95% CI: 1.8-12.5; p = 0.002), followed by
those with the vacA-s1 gene (OR = 2.8, 95% CI: 1.1-7.4;
p = 0.031), while those with vacA-s2 had the lowest pro-
portion of PUD (OR = 0.3, 95% CI: 0.1-0.7; p = 0.011).
The presence of both cagA and vacA-s1 gene increased
the risk of PUD more than the presence of these
genotypes individually (OR = 6.3, 95% CI: 1.6-23.4;
p = 0.006).
Table 4 shows the correlation between level of IL-8 in
the gastric mucosa and H. pylori genotypes and histo-
logic features and PUD. The median value for IL-8 was
significantly higher in patients infected with H. pylori
with cagA (p = 0.011) and vacA-s1 genes (p = 0.011 and
0.024, respectively); and significantly lower in those with
vacA-s2 gene (p = 0.004) (Figure 1). The highest levels
of IL-8 were found in patients who were positive for
both cagA and vacA-s1 (Figure 2). Correlation of gastric
mucosal IL-8 levels with the severity of chronic inflam-
mation showed that patients who had “Moderate-
Marked” chronic inflammation had significantly higher
median IL-8 level compared to those who had “None-
Mild” inflammation (p = 0.001) (Figure 3). Patients with
“Moderate-Marked” neutrophil activity on gastric bi-
opsy also had significantly higher median IL-8 levels
compared to those who had “None-Mild” activity (p =
0.007). The median levels of IL-8 were also significantly
elevated in the gastric biopsies of patients with PUD
compared to those who did not have ulcers (p = 0.001).
There was no significant difference in the density of H.
pylori or degree of glandular atrophy or intestinal meta-
plasia with the IL-8 level in the gastric biopsies.
A total of 58 (75.3%) patients who had “Moderate-
Marked” chronic inflammation in the gastric mucosa
had PUD, compared to 12 (54.5%) with “None-Mild”;
Table 2 Results of endoscopic, histological, H. pylori
genotype, and IL-8 level in patients with H. pylori
infection in Kuwait
Characteristic
n %
Esophagogastroduodenoscopy findingsa
Duodenal ulcer 61 (61.6)
Gastritis 57 (57.6)
Duodenitis 29 (29.3)
Gastric ulcer 13 (13.1)
Esophagitis 10 (10.1)
Gastric cancer 1 (1.0)
Histological findingsb
H. pylori present 98 (99.0)
None-Mild 44 (44.4)
Moderate-Marked 54 (54.5)
Chronic inflammation
None-Mild 22 (22.2)
Moderate-Marked 77 (77.8)
Neutrophil activity
None-Mild 60 (60.6)
Moderate-Marked 39 (39.4)
Glandular atrophy
None-Mild 65 (65.7)
Moderate-Marked 34 (34.3)
Intestinal metaplasia
None-Mild 94 (94.9)
Moderate-Marked 5 (5.1)
H. pylori genotype
cagA 52 (52.5)
vacA-s1 44 (44.4)
vacA-s2 39 (39.4)
vacA-s1 + s2 10 (10.1)
cagA + vacA-s1 31 (31.3)
cagA + vacA-s2 8 (8.1)
cagA + vacA-s1 + s2 7 (7.1)
IL-8 Level(pg/mg protein)
Mean ± SD 1891.5 ± 1526.8
Median (IQR) 1567.4 (1566.3)
aSome patients had more than one finding on endoscopy.
bAccording to the Updated Sydney system [40].
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Table 3 Association between H. pylori genotypes and chronic inflammation, neutrophil activity and peptic ulcer disease
H. pylori
genotypea (n)
Chronic inflammationb Neutrophil activityb Peptic Ulcer Disease
None-Mild Moderate-Marked OR
(95% CI)c
p-value None-Mild Moderate-Marked OR
(95% CI)c
p-value Absent Present OR
(95% CI)c
p-value
(n 22) (n 77) (n 60) (n 39) (n 29) (n 70)
n (%) n (%) n (%) n (%) n (%) n (%)
cagA
Positive (52) 8 (15.4) 44 (84.6) 2.4 (0.9-6.7) 0.074 29 (55.8) 23 (44.2) 1.5 (0.6-3.4) 0.325 8 (15.4) 44 (84.6) 4.8 (1.8-12.5) 0.002*
Negative (47) 14 (29.8) 33 (70.2) Reference 31 (66.0) 16 (34.0) Reference 21 (44.7) 26 (55.3) Reference
vacA-s1
Positive (44) 5 (11.4) 39 (88.6) 3.9 (1.2-12.0) 0.017* 22 (50.0) 22 (50.0) 2.2 (0.9-5.2) 0.057 8 (18.2) 36 (81.8) 2.8 (1.1-7.4) 0.031*
Negative (55) 17 (30.9) 38 (69.1) Reference 38 (69.1) 17 (30.9) Reference 21 (38.2) 34 (61.8) Reference
vacA-s2
Positive (39) 13 (33.3) 26 (66.7) 0.3 (0.1-0.8) 0.025* 29 (74.4) 10 (25.6) 0.3 (0.1-0.8) 0.027* 17 (43.6) 22 (56.4) 0.3 (0.1-0.7) 0.011*
Negative (60) 9 (15.0) 51 (85.0) Reference 31 (51.7) 29 (48.3) Reference 12 (20.0) 48 (80.0) Reference
vacA-s1 + S2
Positive (10) 3 (30.0) 7 (70.0) 0.5 (0.1-2.2) 0.445 8 (80.0) 2 (20.0) 0.3 (0.0-1.7) 0.191 2 (20.0) 8 (80.0) 1.8 (0.3-9.1) 0.478
Negative (89) 19 (21.3) 70 (78.7) Reference 52 (58.4) 37 (41.6) Reference 27 (30.3) 62 (69.7) Reference
cagA + vacA-s1
Positive (31) 2 (6.5) 29 (93.5) 6.7 (1.4-31.4) 0.016* 18 (58.1) 13 (41.9) 0.9 (0.9-1.0) 0.737 3 (9.7) 28 (90.3) 6.3 (1.6-23.4) 0.006*
Negative (68) 20 (20.9) 48 (70.6) Reference 42 (61.8) 26 (38.2) Reference 26 (38.2) 42 (61.8) Reference
cagA + vacA-s2
Positive (8) 3 (37.5) 5 (62.5) 0.4 (0.1-2.2) 0.337 5 (62.5) 3 (37.5) 0.9 (0.2-4.3) 0.959 2 (25.0) 6 (75.0) 1.2 (0.2-6.5) 0.810
Negative (91) 19 (20.9) 72 (79.1) Reference 55 (60.4) 36 (39.6) Reference 27 (29.7) 64 (70.3) Reference
cagA + vacA-s1 + s2
Positive (7) 2 (28.6) 5 (71.4) 0.9 (0.9-1.0) 0.255 5 (71.4) 2 (39.4) 0.5 (0.1-3.2) 0.537 1 (14.3) 6 (85.7) 2.7 (0.3-24.5) 0.359
Negative (92) 20 (21.7) 72 (78.3) Reference 55 (59.8) 37 (40.2) Reference 28 (30.4) 64 (69.6) Reference
aAll patients were positive for either cagA, vacA or both.
bAccording to the Updated Sydney system [40].
cAge and gender adjusted odds ratio.
*Statistically significant.
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while 31 (79.5%) patients with “Moderate-Marked” neu-
trophil activity had PUD, compared to 39 (65.0%) of
those with “None-Mild” activity. However these differ-
ences were not statistically significant. There was also no
association between the presence of PUD and severity of
glandular atrophy, intestinal metaplasia or H. pylori dens-
ity on gastric biopsies.
Discussion
To our knowledge, this is the first study to examine the
association between the presence of cagA, vacA-s1 and
vacA-s2 genotypes in H. pylori and the severity of
chronic gastritis and PUD in a group of patients from
the Middle East. We have also demonstrated the rela-
tionship of these factors with the levels of IL-8 in the
gastric mucosa validating the biologic plausibility that
these bacterial virulence factors lead to induction of the
cytokine IL-8, which in turn results in more severe in-
flammation and/or development of PUD.
There appears to be a geographic variation in the asso-
ciation between H. pylori genotypes and gastric inflam-
matory response. Infection with cagA positive strains of
H. pylori in Western countries is reported to cause more
severe gastric inflammation compared to Asian coun-
tries, where the results have been inconsistent [7,20-24].
In our study both the degree of chronic inflammation
and neutrophil activity in the gastric mucosa were more
severe in patients who were infected with H. pylori con-
taining the cagA and vacA-s1 genes. The presence of
both cagA and vacA-s1 appeared to have a synergistic
role in increasing the severity of inflammation in our pa-
tients. On the other hand, the presence of vacA-s2 ap-
peared to improve the severity of chronic inflammation
as well as neutrophil activity regardless of the presence
of cagA, vacA-s1 or both. These findings are consistent
with previously published studies where vacA-s2 strains
were found to be associated with less inflammation [25].
Both the cagA and vacA-s1 genes were also independ-
ently associated with an increased risk of PUD, while the
vacA-s2 gene appeared to have a lesser effect. Patients
who had both the cagA and the vacA-s1 gene had the
highest risk of PUD. On the other hand, the presence of
vacA-s2 decreased the risk of PUD, whether it was
present alone or with cagA, vacA-s1, or both. These re-
sults are similar to those reported from the Western
countries [20,21,24], even though the majority of the pa-
tients in our study were from the Middle East and the
Indian Subcontinent [26]. A recent study conducted to
determine the genetic affinities of H. pylori isolates from
ethnic Arabs in Kuwait found that these strains are
closely related to the Indo-European group of the organ-
ism and clearly distinct from the East Asian strains [27].
This could be the reason why the association of cagA,
vacA-s1 and vacA-s2 and gastritis and PUD in our pa-
tients seems to be similar to that reported from the
Western countries.
The pro-inflammatory cytokine IL-8 plays an import-
ant role in the regulation of mucosal neutrophil migra-
tion and activation. Our results show that the level of
IL-8 in the gastric mucosa was increased in presence of
cagA and vacA-s1 genotypes of H. pylori and the highest
levels were seen in patients who were positive for both
Table 4 Correlation between interleukin-8 and H. pylori
genotypes, chronic inflammation, neutrophil activity, and
peptic ulcer disease
H. pylori genotypea Interleukin-8 levelb p-valuec
Median (IQR)
cagA
Absent 1090.3 (1310.8) 0.011*
Present 1885.7 (1281.6)
vacA-s1
Absent 1245.8 (1550.2) 0.024*
Present 1840.0 (1098.6)
vacA-s2
Absent 1840.0 (1597.5) 0.004*
Present 965.6 (1205.1)
vacA-s1 + s2
Absent 1541.1 (1566.3) 0.818
Present 1711.8 (1928.7)
cagA + vacA-s1
Absent 1311.8 (1814.9) 0.021*
Present 1901.7 (915.3)
cagA + vacA-s2
Absent 1577.5 (1548.6) 0.713
Present 1331.7 (−)
cagA + vacAs1 + s2
Absent 1541.1 (1625.9) 0.807
Present 1711.8 (1803.6)
Histological findingsd
Chronic inflammation
None-Mild 689.2 (1420.6) 0.001*
Moderate-Marked 1835.7 (1345.3)
Neutrophil activity
None-Mild 1449.0 (1342.1) 0.007*
Moderate-Marked 1917.8 (2703.6)
Peptic ulcer
Absent 919.3 (1153.3) 0.001*
Present 1890.6 (1638.4)
aAll patients were positive for either cagA, vacA or both.
bpg/mg protein.
cMann-Whitney U test.
dAccording to the Updated Sydney system [40].
*Statistically significant
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these genes. The presence of vacA-s2 was associated
with lower levels of IL-8. Significantly higher levels of
IL-8 in the gastric mucosa were also seen in patients
who had more severe degree of chronic inflammation
and neutrophil activity in the gastric biopsies, as well as
those who had PUD. These results are in agreement with
previous reports where the levels of gastric mucosal IL-8
levels have been correlated with the presence of viru-
lence H. pylori genes such as cagA and ice A [28,29].
However, some researchers have reported no difference
in the IL-8 levels in patients with H. pylori infections
with and without PUD [30], while others have higher
levels in patients with PUD then those with only gastritis
[31]. This inconsistency in the results of IL-8 production
could be because of the differences in the methodologies
used to measure the level of the cytokine in the gastric mu-
cosa. We have used an ELISA based technique, which may
be a more sensitive method of cytokine quantification.
With reference to other factors, we found no difference
in the severity of gastritis, presence of PUD or levels of IL-
8 between patients with or without history of smoking or
alcohol consumption. The presence of PUD was however
more frequent in this group of patients than has been re-
ported previously from Kuwait as well as elsewhere [32].
The confounding effects of medications were minimized
by only selecting those patients who had not been on any
Figure 1 Levels of interleukin-8 in the gastric mucosa in patients with H. pylori with and without genotypes cagA, vacA-s1 and vacA-s2.
These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th percentile is indicated with a line, and the
10th and 90th percentiles are indicated with error bars. The p-values were calculated using the Mann–Whitney U test. *indicates that the p-value is
statistically significant.
Figure 2 Levels of interleukin-8 in the gastric mucosa in patients with H. pylori with and without genotypes cagA + vacA-s1, cagA +
vacA-s2 and cagA + vacA-s1 + vacA-s2. These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th
percentile is indicated with a line, and the 10th and 90th percentiles are indicated with error bars. The p-values were calculated using the
Mann–Whitney U test. *indicates that the p-value is statistically significant.
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of the mentioned medications for at least 4 weeks prior to
endoscopy. Several other H. pylori factors such as vacA-s1
subtypes (s1a and s1b), vacA middle region subtypes (m1
and m2), iceA and dupA genes can also affect the viru-
lence of this organism and its effects on the gastric mu-
cosa [33]. However, our study was not designed to
determine these virulence factors, and this could be con-
sidered a limitation of this report. Besides bacterial factors,
host genetics also contribute to the pathogenesis of gas-
troduodenal diseases [34,35]. In addition, many cytokine
gene polymorphisms reveal different risk in gastric and
duodenal ulcer patients [36,37].
Conclusions
This study which included patients from the Middle East
shows that presence of H. pylori cagA and vacA-s1 genes
results in induction of higher levels of the pro-
inflammatory cytokine IL-8 in the gastric mucosa, which
not only results in a more marked intensity of chronic in-
flammation and neutrophil activity in the gastric mucosa
but also a higher occurrence of PUD. The presence of
vacA-s2 results in lower levels of IL-8, as well as less se-
vere inflammation and less PUD. In addition the presence
of vacA-s2 appears to lessen the virulence effects of cagA
and/or vacA-s1 genes.
Patients and methods
Patients and samples
The study population and the method of biopsy collec-
tion have been described previously [26,32]. Briefly, 120
consecutive, unselected adult patients referred for eso-
phagogastroduodenoscopy were invited to participate in
the study. Patients with coagulation abnormalities, prior
gastro-duodenal surgery were excluded from the study.
Patients who had taken histamine type 2 receptor antag-
onists, proton pump inhibitors, antibiotics, bismuth
salts, aspirin or non-steroidal anti-inflammatory agents
in the preceding four weeks were also excluded. The
prevalence of cagA and vacA genotypes in these patients
has been reported earlier [26].
Upper gastrointestinal endoscopy was performed in a
standard manner. All endoscopes underwent a cleaning
and disinfection process with an automated washer-
disinfector before each procedure according to guide-
lines of the European Society of Gastrointestinal Endos-
copy [38]. For each patient, four biopsies were taken
from the gastric antrum, within 2 cm of the pylorus,
using sterilized biopsy forceps.
Two biopsy specimens were fixed in buffered formalin,
processed to paraffin, sectioned and stained with H&E
and the HpSS [39]. All biopsies were examined individu-
ally by a senior gastrointestinal pathologist who was
blinded to the clinical information about the patients. A
biopsy was scored positive for H. pylori if organisms
were seen on light microscopy. The updated Sydney
system was used to score the density of H. pylori and
degree of chronic inflammation, neutrophil activity,
glandular atrophy and intestinal metaplasia on the biop-
sies [40]. Patients who had no or mild chronic inflam-
mation in the gastric biopsy were combined in one
group (None-Mild group), while those with moderate or
marked degree of inflammation were included in the
other group (Moderate-Marked group). Similarly, pa-
tients were divided into two groups (i.e. None-Mild and
Moderate-Marked) for neutrophil activity, as well as for
intestinal metaplasia and glandular atrophy.
Figure 3 Levels of interleukin-8 in the gastric mucosa in patients with H. pylori and severity of chronic inflammation, neutrophil
activity and peptic ulcer disease. These are expressed as box plots. The ends of the bars indicate the 25th and 75th percentiles. The 50th
percentile is indicated with a line, and the 10th and 90th percentiles are indicated with error bars. The p-values were calculated using the Mann–
Whitney U test. * indicates that the p-value is statistically significant.
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The QIAamp® DNA mini kit (Qiagen, Hilden, Germany)
was used to extract DNA from the biopsies. The purity of
DNA was assessed calculating the ratio of optical density
(OD) at 260–280 nm and the yield was quantified by ab-
sorbance at 260 nm.
PCR amplification of target DNA
Table 5 shows the primers used in this study. The cagAF
and cagAR primers generate a fragment of 183 base
pairs (bp) for the detection of cagA, while primers VA1F
and VA1XRA yield a 176 bp fragment for vacA-s1 and
203 bp for vacA-s2 variants [41,42]. A pre-aliquoted
PCR master mix (Abgene, Surrey, UK) was used for
PCR amplification of target DNA. The final reaction
volume was 50 μL and contained 25pmol of each primer
and 50 ng DNA [43]. PCR was performed after preincu-
bation at 94°C for 5 minutes, followed by 35 cycles at
94°C , 50°C and 74°C for one minute each followed by a
5 minutes final extension step at 74°C. The amplified
samples were analyzed by electrophoresis on 2% high-
resolution agarose gel in Tris–Acetate–EDTA (TAE) buf-
fer, which was then stained with ethidium bromide at
0.5 μg/ml [44]. Ultraviolet light was used to visualize the
bands of amplified DNA, which were then photographed.
Measurement of IL-8
Two biopsy specimens were frozen immediately in liquid
nitrogen and stored at −80°C. These samples were later
homogenized with 1 mL phosphate buffered saline
(pH 7.4) for 1 minute at 4°C. The homogenate was then
centrifuged for 10 minutes at 14,000 rpm. The super-
natant obtained was used for estimation of IL-8 level as
well as total protein measurement [45-47]. The IL-8 con-
centration was measured by IL-8 ELISA kit (Immunotech,
Hamburg, Germany) in a sandwich type assay using the
procedure recommended by the manufacturer. The modi-
fied Lowry method was used to measure the total protein
in the homogenate [48]. The amount of IL-8 in the gastric
mucosal biopsies was expressed as pg/mg protein.
Statistical analysis
The Student’s t-test was used to compare the difference
between two means. We evaluated the association of PUD
and severity of inflammation with the three H. pylori ge-
notypes (cagA, vacA-s1 and vacA-s2) and their combina-
tions. As our outcome measures were binary variables, we
used univariate logistic regression models to test if any of
the genotypes or their combinations are related to pres-
ence of the PUD or severity of inflammation. The strength
of the association between these variables obtained from
the regression models was expressed as the odds ratio
(OR) and 95% Confidence Interval (95% CI) along with p-
values. Further multivariate logistic regression models
were used to obtain age and gender adjusted estimates of
these effects. We used Mann–Whitney U tests to evaluate
if the levels of IL-8 correlated with varying genotypes or
their combinations, severity of inflammation and presence
of PUD. We used non-parametric method as the cytokines
were not normally distributed. A p-value of <0.05 was
considered statistically significant. All p-values presented
are two sided. The data were analyzed using the SPSS soft-
ware (SPSS Inc., Chicago, IL, USA).
The protocol for the study, and the statement of in-
formed consent, was approved by the ethical committee
of the Medical Research Council of the Health Sciences
Center at Kuwait University and conforms to the provi-
sions of the World Medical Association’s Declaration of
Helsinki in 1995 (as revised in Tokyo 2004). All patients
gave an informed consent prior to inclusion in the study.
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Table 5 Primers used in PCR for amplification of cagA, vacA-s1 and vacA-s2 sequences
DNA region amplified Primer Primer sequence PCR product (bpa)
cagA cagAF 5′-TTGACCAACAACCACAAACCGAAG-3′ 183
cagAR 5′-CTTCCCTTAATTGCGAGATTCC-3′
vacA-s1 VA1F 5′-ATGGAAATACAACAAACACAC-3′ 176
VA1XRA 5′-CCTGAAACCGTTCCTACAGC-3′
vacA-s2 VA1F 5′-ATGGAAATACAACAAACACAC-3′ 203
VA1XRA 5′-CCTGAAACCGTTCCTACAGC-3′
abp: Base pair.
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